lactic acid has been researched along with paliperidone palmitate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Liu, X; Sun, F; Wang, A; Wang, D; Wang, L; Zhao, X | 1 |
| D'Souza, S; DeLuca, P; Faraj, J | 1 |
| Fan, C; Li, Y; Liu, W; Liu, X; Su, Z; Sun, F; Wang, D; Wang, L; Yu, K; Zhao, J; Zhao, X | 1 |
| Li, Y; Liu, J; Liu, N; Liu, X; Sun, F; Teng, L; Wang, D; Yu, C | 1 |
4 other study(ies) available for lactic acid and paliperidone palmitate
| Article | Year |
|---|---|
Design of a long-term antipsychotic in situ forming implant and its release control method and mechanism.
Topics: Animals; Antipsychotic Agents; Delayed-Action Preparations; Dimethyl Sulfoxide; Dizocilpine Maleate; Dogs; Drug Implants; Excipients; Excitatory Amino Acid Antagonists; Gels; Isoxazoles; Kinetics; Lactic Acid; Male; Mice; Microscopy, Electron, Scanning; Microspheres; Paliperidone Palmitate; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Pyrrolidinones; Solubility; Solutions; Solvents; Stereotyped Behavior | 2012 |
Microsphere delivery of Risperidone as an alternative to combination therapy.
Topics: Animals; Antipsychotic Agents; Area Under Curve; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Delivery Systems; Isoxazoles; Lactic Acid; Male; Microspheres; Paliperidone Palmitate; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Time Factors | 2013 |
Development of near zero-order release PLGA-based microspheres of a novel antipsychotic.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Disease Models, Animal; Dizocilpine Maleate; Dogs; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Liberation; Lactic Acid; Male; Mice; Microspheres; Paliperidone Palmitate; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs; Schizophrenia; Solubility; Time Factors | 2017 |
Butyl stearate prolongs the drug release period of isoperidone‑loaded poly (lactic‑co‑glycolic acid) microspheres: In vitro and in vivo investigation.
Topics: Animals; Delayed-Action Preparations; Dogs; Drug Compounding; Drug Liberation; Humans; Lactic Acid; Microspheres; Paliperidone Palmitate; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Schizophrenia; Stearates | 2019 |